Company
Beijing Increasepharm Corporation Limited is committed to extensive research and development of innovative drugs. Founded in 1999, Increasepharm has since established eight subsidiaries across China. We keep in step with the latest national technology development plan in the Greater Bay Area and expand the Group's overseas international R&D business. Increasepharm (HK) Limited was founded in 2018 to bridge the overall biotechnology development planning between Hong Kong and the Greater Bay Area.
Description
Bridging biotechnology development planning between Hong Kong and the Greater Bay Area